PT2883057T - Diagnóstico de insuficiência cardíaca - Google Patents

Diagnóstico de insuficiência cardíaca

Info

Publication number
PT2883057T
PT2883057T PT13747847T PT13747847T PT2883057T PT 2883057 T PT2883057 T PT 2883057T PT 13747847 T PT13747847 T PT 13747847T PT 13747847 T PT13747847 T PT 13747847T PT 2883057 T PT2883057 T PT 2883057T
Authority
PT
Portugal
Prior art keywords
heart failure
failure diagnosis
diagnosis
heart
failure
Prior art date
Application number
PT13747847T
Other languages
English (en)
Portuguese (pt)
Inventor
Rouet Philippe
Smih-Rouet Fatima
Desmoulin Franck
Galinier Michel
Original Assignee
Univ Toulouse 3 Paul Sabatier
Inst Nat Sante Rech Med
Ct Hospitalier Universitaire Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toulouse 3 Paul Sabatier, Inst Nat Sante Rech Med, Ct Hospitalier Universitaire Toulouse filed Critical Univ Toulouse 3 Paul Sabatier
Publication of PT2883057T publication Critical patent/PT2883057T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4745Insulin-like growth factor binding protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44717Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/4473Arrangements for investigating the separated zones, e.g. localising zones by electric means
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/325Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • External Artificial Organs (AREA)
  • Paper (AREA)
PT13747847T 2012-08-09 2013-08-09 Diagnóstico de insuficiência cardíaca PT2883057T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12305988 2012-08-09

Publications (1)

Publication Number Publication Date
PT2883057T true PT2883057T (pt) 2019-03-06

Family

ID=48953397

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13747847T PT2883057T (pt) 2012-08-09 2013-08-09 Diagnóstico de insuficiência cardíaca

Country Status (16)

Country Link
US (2) US20150219669A1 (enExample)
EP (1) EP2883057B1 (enExample)
JP (2) JP6298054B2 (enExample)
CY (1) CY1121406T1 (enExample)
DK (1) DK2883057T3 (enExample)
ES (1) ES2713098T3 (enExample)
HR (1) HRP20190341T1 (enExample)
HU (1) HUE042708T2 (enExample)
LT (1) LT2883057T (enExample)
PL (1) PL2883057T3 (enExample)
PT (1) PT2883057T (enExample)
RS (1) RS58553B1 (enExample)
SI (1) SI2883057T1 (enExample)
SM (1) SMT201900108T1 (enExample)
TR (1) TR201902555T4 (enExample)
WO (1) WO2014023820A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3004891T3 (pl) 2013-06-06 2019-09-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarker ponownej hospitalizacji po niewydolności serca
US11839614B2 (en) * 2018-01-31 2023-12-12 Intra-Cellular Therapies, Inc. Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression
EP4056585A4 (en) * 2019-11-06 2024-03-13 National University Corporation Kagawa University HEART FAILURE MARKER
CN120053474B (zh) * 2025-02-26 2025-12-12 浙江大学 辅酶a在制备心肌细胞铁死亡抑制剂中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183681A1 (en) * 2005-02-14 2006-08-17 Bio-Rad Laboratories, Inc. Stabilized compositions containing natriuretic peptides
JP4465469B2 (ja) * 2005-02-21 2010-05-19 国立大学法人佐賀大学 循環器病マーカーとしてのインターロイキン13
EP1722232A1 (en) 2005-05-09 2006-11-15 F.Hoffmann-La Roche Ag Devices and methods for diagnosing or predicting early stage cardiac dysfunctions
US20080166734A1 (en) * 2005-12-21 2008-07-10 David Xing-Fei Deng Genes and methods of using the same for diagnosis and for targeting the therapy of cardiovascular disease
JP5399900B2 (ja) * 2006-06-30 2014-01-29 メルク・シャープ・アンド・ドーム・コーポレーション Igfbp2インヒビター
JP2010517023A (ja) 2007-01-25 2010-05-20 エフ.ホフマン−ラ ロシュ アーゲー 心不全の評価におけるigfbp−7の使用
EP2310860A1 (en) * 2008-07-30 2011-04-20 INSERM - Institut National de la Santé et de la Recherche Médicale Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure
JP6061344B2 (ja) * 2010-07-14 2017-01-18 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイションCommonwealth Scientific And Industrial Research Organisation 大腸癌の診断
ES2534921T3 (es) * 2010-08-26 2015-04-30 F. Hoffmann-La Roche Ag Uso de biomarcadores en la evaluación de la transición temprana de la hipertensión arterial a la insuficiencia cardíaca
EP2841945A4 (en) 2012-04-24 2016-04-27 Astute Medical Inc METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING OF STROKE OR OTHER BRAINS
WO2014116708A1 (en) * 2013-01-22 2014-07-31 Singulex, Inc. Endothelin in the diagnosis of cardiac disease

Also Published As

Publication number Publication date
US20180143208A1 (en) 2018-05-24
CY1121406T1 (el) 2020-05-29
TR201902555T4 (tr) 2019-03-21
US11061037B2 (en) 2021-07-13
JP2015528562A (ja) 2015-09-28
PL2883057T3 (pl) 2019-07-31
US20150219669A1 (en) 2015-08-06
EP2883057A1 (en) 2015-06-17
EP2883057B1 (en) 2018-12-05
HUE042708T2 (hu) 2019-07-29
WO2014023820A1 (en) 2014-02-13
LT2883057T (lt) 2019-04-25
RS58553B1 (sr) 2019-05-31
JP2018109640A (ja) 2018-07-12
JP6298054B2 (ja) 2018-03-20
ES2713098T3 (es) 2019-05-17
HRP20190341T1 (hr) 2019-05-31
DK2883057T3 (en) 2019-03-18
JP6595641B2 (ja) 2019-10-23
SI2883057T1 (sl) 2019-07-31
SMT201900108T1 (it) 2019-05-10

Similar Documents

Publication Publication Date Title
IL275998B (en) Medical system
EP2916905A4 (en) MEDICAL CONNECTOR
EP2842540A4 (en) MEDICAL CONNECTOR
DK2863990T3 (da) Medicinsk mikroelektrode
EP2903509A4 (en) PORTABLE HEART MONITOR
EP4379102C0 (en) PATIENT INTERFACE
EP2830692A4 (en) Patient interface
BR302012004879S1 (pt) Configuração aplicada em esfigmomanômetro
EP2921192A4 (en) CATHETER
EP2837341A4 (en) MEDICAL MANIPULATOR
EP2823767A4 (en) CATHETER
EP2903542A4 (en) MEDICAL ATTACHE
EP2902071A4 (en) INTERCONNECTS
EP2719338A4 (en) ULTRASOUND ENDOSCOPE
BR112014031335A2 (pt) bloco de diagnóstico transacional
EP2926857A4 (en) Catheter
FR2998638B1 (fr) Raccord
EP2759249A4 (en) Endoscope system
EP2735260A4 (en) Endoscope
BR302012005886S1 (pt) Configuração aplicada em adesivo médico
DK4001436T3 (da) Diagnostisk genmarkørpanel
EP3925535C0 (en) CARDIAC ACTIVATION TIME DETECTION
EP2765913A4 (en) LANCET
FI20125887A7 (fi) Järjestely biosignaalin mittaamiseksi
EP2740411A4 (en) ULTRASOUND ENDOSCOPE